Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
NVDA -0.4EWJ 0.37TECK.B.TO -2.09CNQ.TO 0.71HHL.TO 0.075SYLD 0.03HAC.TO 0.04TRU -0.01
Daily Stock Opinions and Ratings
Stockchase Opinions

Jordan ZinbergQuipt Home MedicalQIPT.VWATCHJul 04, 2023

Owns a small position, but wants to see better momentum before adding more. They did a raise of $7.85 a few months ago and shares have been weak since. Are digesting their latest acquisition and should rise higher.

Jordan ZinbergJordan Zinberg
Owned
Unlock Rating
$7.28

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist
Track your Stocks in your Watch List

You might be interested:

COMMENT

Quipt Home Medical(QIPT.V)

Jan 15, 2024

This used to be called Patient Home Monitoring at one point. It is very cheap, has been performing and executing acquisitions pretty consistently. The CEO and management have done very well. The small cap health care sector is quiet but due to Quipt's good value it could be a takeover candidate.

Photo of Jordan ZinbergJordan ZinbergUnlock Rating
$7.28

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
TOP PICK

Quipt Home Medical(QIPT.V)

Sep 13, 2023

Continues to execute really well both organically and by acquisition. Sold off recently on management missteps on financing. Very attractive valuation, about 1/2 that of peers. Too cheap with the growth rate. No dividend.

(Analysts’ price target is $14.35)
Photo of Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$7.28

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
RISKY

Quipt Home Medical(QIPT.V)

Sep 05, 2023

The chart if forming a cup (not bad), but swings lately are troublesome. Not for the timid. Very choppy. Maybe trade this, but be careful; resistance at $9.

Photo of Keith RichardsKeith RichardsUnlock Rating
$7.28

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
BUY ON WEAKNESS

Quipt Home Medical(QIPT.V)

Jul 28, 2023

Does not own shares at the moment.
Lots of tailwinds with aging population.
Strong growth from demand for healthcare.
Capital markets have punished stock price due to questionable equity financing. 
Pressure in stock price is creating a buying opportunity.

Photo of Bruce Campbell (2)Bruce Campbell (2)Unlock Rating
$7.28

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
BUY ON WEAKNESS

Quipt Home Medical(QIPT.V)

Feb 03, 2023

Low valuation for in-home medical services company.
Does not own shares in the company, but has owned in the past.
Looking into buying shares in the future.
Management team has done great job growing company.


Photo of Jordan ZinbergJordan Zinberg
No
Unlock Rating
$7.92

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
BUY

Quipt Home Medical(QIPT.V)

Jan 25, 2023

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Company recently acquired (Great Elm). At $80M it is a sizeable deal, but adds $60M in revenue and $13M in EBITDA. Should be $2M in cost savings and it is accretive to cash flow. The market likes the deal. Good earnings growth is expected. Unlock Premium - Try 5i Free

Photo of Stockchase InsightsStockchase InsightsUnlock Rating
$8.00

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
TOP PICK

Quipt Home Medical(QIPT.V)

Jan 19, 2023
Trades at significant discount of 2 multiple points to peers. Grows organically and by acquisition. CPI increase to Medicare and Medicaid has delivered price increases. No dividend. (Analysts’ price target is $14.20)
Photo of Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$7.70

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
Unspecified

Quipt Home Medical(QIPT.V)

Nov 21, 2022
The underlying business is doing well but the stock is way down. It has a fortified balance sheet, is growing organically`and by acquisition. They have set up a recent bank arrangement for this. It should move in line with its peers.
Photo of Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$5.80

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
PAST TOP PICK

Quipt Home Medical(QIPT.V)

Oct 21, 2022

(A Top Pick Nov 19/21, Down 35%) Respiration industry (repository technology and machines). Business growing well. Revenue growing with profits. Trading at 50% of multiple compared to peers. Will continue to hold shares.

Photo of Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$5.60

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
PAST TOP PICK

Quipt Home Medical(QIPT.V)

Aug 22, 2022
(A Top Pick Sep 02/21, Down 19%) It deals in home care products, e.g. oxygen, etc. It has been growing the business by 30% over the year but the stock price is down because it is a small cap company. A different market moves them substantially higher. A recent banking deal allows for more acquisitions. It is moving from a regional player to a national one. Next year a lot of catalysts could move it higher.
Photo of Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$6.81

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
WATCH

Quipt Home Medical(QIPT.V)

Jul 11, 2022
It is a Canadian company operating in just the U.S. The CEO has done a good job growing the business. It screens cheaply but needs more consistent profitability.
Photo of Jordan ZinbergJordan Zinberg
No
Unlock Rating
$6.57

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
PAST TOP PICK

Quipt Home Medical(QIPT.V)

Jul 04, 2022
(A Top Pick Sep 02/21, Down 30%) Health care is moving into homes so it is in a good spot. It is still making accretive acquisitions and guiding 30% higher revenue. It is in 19 states. He continues to hold the debentures.
Photo of Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$6.10

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
BUY

Quipt Home Medical(QIPT.V)

Jan 31, 2022

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Revenues have grown 41% since 2020 at $102M for 2021. 10% organic growth. Operational metrics are impressive that sets up the company well for future recurring revenues. Still some runway left, trading at 22x earnings. The balance sheet is healthy with net cash. Unlock Premium - Try 5i Free

Photo of Stockchase InsightsStockchase Insights
Unknown
Unlock Rating
$6.71

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare
TOP PICK

Quipt Home Medical(QIPT.V)

Nov 19, 2021
Home healthcare business with chronically ill patients. Growing organically at 10% per year. They are also acquiring companies and just announced 2 acquisitions. Fantastic margin at 22% EBITDA. The stock trades at 6x next year's EBITDA compared to 10x for their peers. Buying more right now. Will go higher as it gets rerated. (Analysts’ price target is $12.23)
Photo of Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$8.66

Stock price when the opinion was issued

$7.28

As of Jun 20, 2023. Market Open.

Healthcare

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VEEV 0$153.3
WSP.TO 1.13$176.7
VRTX 0.47$452.1
OTEX.TO 0.24$29.47
CCO.TO 0.61$151.07

Today's Top Picks

NVDA -0.4$210.29
EWJ 0.37$96.63
TECK.B.T… -2.09$88.93
CNQ.TO 0.71$58.66
HHL.TO 0.075$6.865

Popular Articles

Latest Sell Signals

TD.TO 0.7$169.33
MBLY -0.03$8.43
ASAN 0.03$6.95
MODG -0.01$18.21
NVTS 0$24.02

Most Recent Experts

Stockchase Insights

Stockchase Insights

5i Research

Brian Acker, CA

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica